Capricor Therapeutics | 8-K: Current report
Capricor Therapeutics | 8-K: Current report
Capricor Therapeutics | 8-K: Capricor Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Capricor Therapeutics | 8-K: Current report
Capricor Therapeutics | DEF 14A: Definitive information statements
Capricor Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Capricor Therapeutics | 8-K: Capricor Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Capricor Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Capricor Therapeutics | 8-K: Current report
Capricor Therapeutics | 8-K: Current report
Capricor Therapeutics | 8-K: Capricor Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Capricor Therapeutics | 8-K: Current report
Capricor Therapeutics | 8-K: Current report
Capricor Therapeutics | 8-K: Current report
Capricor Therapeutics | 8-K: Capricor Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Capricor Therapeutics | 8-K: Current report
Capricor Therapeutics | 8-K: Current report
Capricor Therapeutics | 8-K/A: Current report (Amendment)
Capricor Therapeutics | 8-K/A: Current report (Amendment)
Capricor Therapeutics | 8-K: Current report
No Data